Overview

Autodisplay Biotech was founded in May 2008 as a spin-off from the Heinrich-Heine University Dusseldorf in Germany.

The management team consists of the three founders

• Prof. Dr. Joachim Jose, CEO
  Head of the Institute of Pharmaceutical and Medicinal Chemistry, Heinrich-Heine University, Dusseldorf
• Dr. Ruth Maas, CSO
  Group Leader at the Institute of Pharmaceutical and Medicinal Chemistry, Heinrich-Heine University, Dusseldorf
• Dr. Gunter Festel, CFO
  Investor and entrepreneur from the Swiss cantone Zug

Each of Autodisplay Biotech's founders has already successfully founded companies, e.g. Pharmacelcus GmbH in Saarbrucken or Butalco GmbH in Huenenberg/Switzerland.

Core business is the development and out-licensing of own intellectual property (IP) as well as the production of selected biocatalysts and bioanalysis tools. Autodisplay Biotech will also act as a service provider in certain areas.

The company already has a strong intellectual property position in its core technology areas and some of the applications like biocatalysis and drug discovery are already or almost developed. Through co-operation agreements, Autodisplay Biotech's own patent situation is strengthend within fundamental technologies, enabling to focus on the application-oriented further development and commercialisation of the autodisplay technology.